Global Markets Direct’s pharmaceuticals report, “TheraCarb Inc. - Product Pipeline Review - 2013” provides data on the TheraCarb Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, TheraCarb Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from TheraCarb Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
- TheraCarb Inc. - Brief TheraCarb Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of TheraCarb Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of TheraCarb Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the TheraCarb Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate TheraCarb Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of TheraCarb Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the TheraCarb Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with TheraCarb Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of TheraCarb Inc. and identify potential opportunities in those areas.
Table Of Contents
TheraCarb Inc. - Product Pipeline Review - 2013 Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 TheraCarb Inc. Snapshot 4 TheraCarb Inc. Overview 4 Key Information 4 Key Facts 4 TheraCarb Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 TheraCarb Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 TheraCarb Inc. - Pipeline Products Glance 9 TheraCarb Inc. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 TheraCarb Inc. - Drug Profiles 11 Drug For AA Amyloidosis 11 Product Description 11 Mechanism of Action 11 RandD Progress 11 Drug For Alzheimer's Disease 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 Drug For Clostridium Difficile Associated Diarrhea 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 Drug For Escherichia coli 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 Immunobait 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 Vaccine for Vaginal Candidiasis 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 TheraCarb Inc. - Pipeline Analysis 17 TheraCarb Inc. - Pipeline Products by Therapeutic Class 17 TheraCarb Inc. - Pipeline Products By Target 19 TheraCarb Inc. - Pipeline Products by Route of Administration 20 TheraCarb Inc. - Pipeline Products By Mechanism of Action 21 TheraCarb Inc. - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables
TheraCarb Inc., Key Information 4 TheraCarb Inc., Key Facts 4 TheraCarb Inc. - Pipeline by Indication, 2013 6 TheraCarb Inc. - Pipeline by Stage of Development, 2013 7 TheraCarb Inc. - Monotherapy Products in Pipeline, 2013 8 TheraCarb Inc. - Preclinical, 2013 9 TheraCarb Inc. - Discovery, 2013 10 TheraCarb Inc. - Pipeline By Therapeutic Class, 2013 18 TheraCarb Inc. - Pipeline By Target, 2013 19 TheraCarb Inc. - Pipeline By Route of Administration, 2013 20 TheraCarb Inc. - Pipeline Products By Mechanism of Action, 2013 21
List of Figures
TheraCarb Inc. - Pipeline by Indication, 2013 6 TheraCarb Inc. - Pipeline by Stage of Development, 2013 7 TheraCarb Inc. - Monotherapy Products in Pipeline, 2013 8 TheraCarb Inc. - Pipeline By Therapeutic Class, 2013 17 TheraCarb Inc. - Pipeline Products By Mechanism of Action, 2013 21